Menu

Department of Military Affairs Tender by Indian Army (GEM/2025/B/6120633)

MDI Fluticasone propionate plus Formoterol 120 MDI,Sulphamethoxazole 400 mg and Trimethoprim 80mg,P

Goods
Qty:23.5K
Department of Military Affairs Tender by Indian Army (GEM/2025/B/6120633)

Tender Timeline

Tender Issue
April 7, 2025 at 7:15 PM

Tender Title: MDI Fluticasone propionate plus Formoterol 120 MDI
Reference Number: GEM/2025/B/6120633
Issuing Authority: Department of Military Affairs, Ministry of Defence

The MDI Fluticasone propionate plus Formoterol 120 MDI tender invites qualified manufacturers to submit their bids for the provision of Fluticasone propionate plus Formoterol in Metered Dose Inhalers (MDI). This pharmaceutical product is critical for treating respiratory conditions and is offered in a total quantity of 23,463 units.

Scope of Work and Objectives

The main objective of this tender is to procure high-quality MDI Fluticasone propionate plus Formoterol to ensure availability for military healthcare facilities. Suppliers are expected to provide a consistent supply of the product while adhering to stringent quality assurance standards.

Eligibility Criteria

Eligible bidders must be registered manufacturers with the capability to fulfill the tender requirements. Compliance with regulatory standards and possessing the necessary certifications are mandatory for participation in this procurement process.

Technical Requirements

The supplied product must meet specific technical specifications, ensuring it aligns with the medical and safety standards applicable in the pharmaceutical field. Documentation proving compliance with quality standards must accompany the bids.

Financial Requirements

Bidders are advised to prepare their financial proposals carefully. Each bid must reflect a competitive pricing structure while ensuring sustainability throughout the procurement lifecycle. Financial stability is essential for consideration.

Document Submission Details

All interested parties must submit the required documents electronically through the specified government e-procurement platform. Complete bid submissions should include technical and financial documentation, aligned with the tender's guidelines.

Special Provisions

Micro, Small, and Medium Enterprises (MSEs) and startups are encouraged to participate, benefitting from provisions designed to enhance their competitiveness in the procurement process. These initiatives aim to bolster local manufacturing under the 'Make in India' campaign.

Evaluation Process

The evaluation process will assess bids based on technical capabilities and value for money. Each submission will undergo a detailed review to ensure compliance with both technical requirements and financial viability.

Delivery Locations

Successful bidders will be required to deliver the goods to designated military healthcare facilities across the country, ensuring timely and efficient distribution of the inhalers.

Contact Information

For more information regarding this tender, parties are encouraged to visit the official Department of Military Affairs procurement portal for further assistance.

This opportunity presents a significant advantage for businesses to engage with a government entity in the healthcare supply domain, contributing to essential services for military personnel.

General Information

Item Category
MDI Fluticasone propionate plus Formoterol 120 MDI , Sulphamethoxazole 400 mg and Trimethoprim 80mg , Pirfenidone 200 mg , Ipratropium Bromide Respirator soln 500 mcg 2 ml respule , Dienogest IP 2 mg , Tiotropium 18 mcg plus Formoterol 6 mcg Metered Dose Inhaler MDI 200 doses with counter , Etophyline 84.7 plus Theophylline 25.3 mg Inj , Theophylline anhydrous syrup 60 mg in 5 ml as 100ml bottle , Formoterol 12 mcg and Fluticasone 250 mcg dry powder , Antimicrobial Hand Gel Containing Ethyl Alcohol 60 percent Cyclomethicone C12 15 Alkyl Lactate Cetyl Lactate Phenoxyethanol Stearyl Alcohol with moisturizer , Vitamin A solution IP 50 ml , Inj Vit B complex Thiamine HCl 100 mg Nicotinamide 100 mg Pyridoxine HCl 5 mg Vit B 12 100 mcg Riboflavin 1 mg D Panthenol 10 mg Choline chloride 100 mg vial of 10 ml , Ethambutol 800 mg , Colchicine 0.5 mg , Cap Amoxycillin 250 mg , Ciprofloxacin 200 mg 100ml Inj , Acyclovir 200 mg , Azithromycin 1 gm plus Fluconazole 150 mg plus Ornidazole 750 mg , Lamivudine 150mg , Inj Pheniramine , Tab Pirfinedone 801 mg , Tab Isolazine 100 mg , Tab Tetrabenazine 25 mg , Tab Amantadine 100 mg
Ministry Name
Organisation Name
State

Financial Information

OEM Average Turnover
₹12.00 Lakh (s)
Minimum Turnover
₹4.00 Lakh (s)
Bid Offer Validity
180 (Days)
Past Performance
50 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

4 Documents
GeM-Bidding-7718273.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover
  • Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Ketamine HCl 50 mg per ml 2 ml Inj,Bupivacaine HCl 5 mg per ml Inj,Fentanyl Citrate 50mcg per ml 2

GEM
Goods
Qty:33.9K
4 Files
Indian Army
KARGIL, JAMMU & KASHMIR
Boq › Boql
Ketamine HCl 50 mg per ml 2 ml Inj , Bupivacaine HCl 5 mg per ml Inj , Fentanyl Citrate 50mcg per ml 2 ml Inj , Dexamethasone 0.5 mg Tab , Baclofen 10 mg Tab , Inj Tenecteplase 20 mg , Enoxaparin 40 mg per 0.4ml Inj , Cilnidipine 5 mg Tab , Cap Probiotic , Itraconazole 100mg Cap , Oral Rehydration powder sachet of 20.5 g , Thyroxine Sodium 0.1mg Tab , Fluticasone Propionate 50 mcg BP Nasal Spray , Clonazepam 0.5 mg Tab , Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCL 10 mg , Nortriptyline 25 mg Tab , Levo Salbutamol Sulphate 2.5 ml containing 1.25 mg Respule , Micronized Purified Flavonoid Fraction of rutaceae 500mg Tab , Tamsulosin HCl 0.4mg Cap , B1 50 mg Inj , Formeterol 6mcg and Budesonide 400 mcgC FC Free MDI 120 Meter dose , Levo- Salbutamol 1.25mg with Ipratropium 500 mcg in 2.5 ml Respule , Fexofenadine Hydrochloride Tab 120 mg , Amoxycillin 1g with Clavulanic Acid 200mg 1.2 gm Inj , Cefoperazone Sodium 1gm and sulbactum Sod 1gm Inj , Teicoplanin 400 mg Inj , Vancomycin CP 500 mg Inj , Meropenem 500 mg Inj , Gauze Surgical Open Wove Unmedicated 60 cm wide , HIV antibody 1 and 2 detection rapid test kit , Troponin T Test card , Rapid card screening for HBV kit of 50 test , Rapid card screening for HCV kit of 50 test , Tab Pantoprazole with Domperidone , Lyse solution, bott of 500ml , Cell Pack pack of 20 ltr , Tab Nilotinib 200mg , Syp Disodium Hydrogen Alkasol, bott of 100 ml , Dengue test card kit of 20 test , Malaria test card kit of 50 test , Typhi Dot test card kit of 50 test , Glucose strip Accu check , Glucometer Cell , Cap Diacerine 50mg , Medical Dry Film 10 inch and 8 inch Fujifilm , Sample Cup , Roter 180 Fully Automatic Machine Erba , Sodium Potassium Chloride kit 180 Fully Automatic , Cholestrol Kit 180 Fully Automatic Erba , Lipase Kit 180 Fully Automatic Erba , CKMB Kit 180 Fully Automatic Erba , CRP Kit 180 Fully Automatic Erba , LDH Kit 180 Fully Automatic Erba , Multi Cal Kit 180 Fully Automatic Erba , ERBA Auto Wash 180 Fully Automatic Erba , ERBA Norm 180 Fully Automatic Erba , ERBA Path 180 Fully Automatic Erba
April 26, 2025
May 17, 2025 at 12:00 PM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered manufacturer capable of producing Fluticasone propionate plus Formoterol. Bidders must provide valid licenses and certifications that confirm their compliance with pharmaceutical standards. Additionally, they need to demonstrate financial stability, ensuring they can fulfill large orders and have a history of reliability in similar procurements.

Required certificates for participation in this tender include pharmaceutical manufacturing licenses, quality control certificates, and any other relevant compliance documentation that showcases adherence to regulatory standards in drug manufacturing.

The registration process involves creating an account on the government e-procurement platform where the tender is hosted. Bidders must submit the necessary corporate documents, including company registration, tax compliance certificates, and relevant licenses, before they can access and submit bids for the tender.

The testing criteria for the MDI Fluticasone propionate plus Formoterol focus on efficacy, safety, and stability. All bids must provide proof of quality assurance tests performed in accredited laboratories, ensuring that the products adhere to the highest pharmaceutical standards.

The Earnest Money Deposit (EMD) is required as part of the submission process to ensure commitment from bidders. The specific amount will be defined in the tender documents, and successful bidders may also need to provide a performance security to guarantee the fulfillment of the contract obligations, ensuring that they adhere to the delivery terms and quality expectations specified in the contract.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders